Jim Simons Neurocrine Biosciences Inc Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,574,546 shares of NBIX stock, worth $317 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
2,574,546
Previous 2,468,146
4.31%
Holding current value
$317 Million
Previous $340 Million
12.77%
% of portfolio
0.47%
Previous 0.6%
Shares
24 transactions
Others Institutions Holding NBIX
# of Institutions
624Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$635 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$230 Million3.62% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$229 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...